1. Home
  2. LU vs MDXG Comparison

LU vs MDXG Comparison

Compare LU & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LU
  • MDXG
  • Stock Information
  • Founded
  • LU 2005
  • MDXG 2006
  • Country
  • LU China
  • MDXG United States
  • Employees
  • LU N/A
  • MDXG N/A
  • Industry
  • LU Finance: Consumer Services
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • LU Finance
  • MDXG Health Care
  • Exchange
  • LU Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • LU 1.4B
  • MDXG 1.1B
  • IPO Year
  • LU 2020
  • MDXG N/A
  • Fundamental
  • Price
  • LU $2.32
  • MDXG $7.46
  • Analyst Decision
  • LU Hold
  • MDXG Strong Buy
  • Analyst Count
  • LU 3
  • MDXG 5
  • Target Price
  • LU $3.58
  • MDXG $12.00
  • AVG Volume (30 Days)
  • LU 2.4M
  • MDXG 1.0M
  • Earning Date
  • LU 10-21-2024
  • MDXG 10-30-2024
  • Dividend Yield
  • LU 6.75%
  • MDXG N/A
  • EPS Growth
  • LU N/A
  • MDXG N/A
  • EPS
  • LU N/A
  • MDXG 0.52
  • Revenue
  • LU $4,671,260,668.00
  • MDXG $342,804,000.00
  • Revenue This Year
  • LU N/A
  • MDXG $9.56
  • Revenue Next Year
  • LU $1.48
  • MDXG $9.19
  • P/E Ratio
  • LU N/A
  • MDXG $18.44
  • Revenue Growth
  • LU N/A
  • MDXG 10.93
  • 52 Week Low
  • LU $2.00
  • MDXG $5.47
  • 52 Week High
  • LU $4.94
  • MDXG $9.48
  • Technical
  • Relative Strength Index (RSI)
  • LU 33.54
  • MDXG 73.10
  • Support Level
  • LU $2.28
  • MDXG $5.69
  • Resistance Level
  • LU $2.89
  • MDXG $7.67
  • Average True Range (ATR)
  • LU 0.12
  • MDXG 0.30
  • MACD
  • LU -0.04
  • MDXG 0.15
  • Stochastic Oscillator
  • LU 5.74
  • MDXG 89.66

About LU Lufax Holding Ltd each representing two (2)

Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: